Contact: research@protoquiz.com

County

Ada County-City Emergency Services System

Current250 dose entries54 drugs5 documentsBoise, IDeffective 2026-02-01100% machine-parsed of 250

Drugs and doses54

A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Clevidipine8

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 6 mg IV not captured standing pages 89, 423
Other adult 6 mg IV not captured standing page 88
Other peds 0.1 mg/kg IV not captured standing pages 89, 423

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2.5 mg NEB not captured standing pages 101, 119, 225
Asthma / bronchospasm peds 2.5 mg NEB not captured standing pages 101, 119, 225
Hyperkalemia adult 5 mg NEB not captured standing page 145

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 300 mg IV/IO not captured standing pages 69, 77, 213
Cardiac arrest peds 5 mg/kg IV/IO not captured standing pages 69, 77, 213
Narrow-complex tachycardia peds 5 mg/kg IV/IO not captured standing page 217
Wide-complex tachycardia adult 150 mg IV/IO not captured standing pages 87, 218, 427
Wide-complex tachycardia peds 5 mg/kg IV/IO not captured standing pages 87, 218, 427

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 324 mg PO not captured standing pages 79, 176

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 1 mg IV/IO not captured standing pages 91, 195, 215
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 91, 195, 215
Organophosphate poisoning adult 1–2 mg IV/IO/IM not captured standing pages 191, 244
Organophosphate poisoning peds 0.02 mg/kg IV/IO/IM not captured standing pages 191, 244

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 500–1000 mg IV not captured standing pages 195, 244, 433
Beta-blocker / calcium-channel-blocker overdose peds 20 mg/kg IV not captured standing pages 195, 244, 433
Hyperkalemia adult 500–1000 mg IV/IO not captured standing pages 70, 145, 433
Hyperkalemia peds 20 mg/kg IV/IO not captured standing pages 70, 145, 433
Other adult 500–1000 mg IV not captured standing page 166

Calcium Gluconate

IndicationPopulationDoseRouteRepeatStandingSource
Hypotension / shock adult 0.5–1 g IV not captured standing page 534

Clevidipine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–16 mg IV not captured standing pages 531, 532
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Droperidol, Epinephrine, Etomidate, Famotidine, Fentanyl11

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 12.5–50 g IV/IO not captured standing page 70
Hypoglycemia adult 12.5–50 g IV/IO not captured standing pages 70, 111, 235, 437
Hypoglycemia peds 5–10 mL/kg IV/IO not captured standing pages 70, 111, 235, 437

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2–5 mg IV not captured standing pages 134, 184
Agitation adult 5–10 mg IM not captured standing pages 134, 184
Other adult 2–5 mg IV/IO/IM not captured standing page 203
Other adult 2–5 mg IV not captured standing page 439
Other adult 5 mg IN not captured standing page 203
Seizure adult 2–10 mg IV/IO not captured standing pages 109, 231
Seizure adult 5–10 mg IM/PR not captured standing pages 109, 231
Seizure peds 0.2 mg/kg IV/IO not captured standing pages 109, 231
Seizure peds 0.5 mg/kg IM/PR not captured standing pages 109, 231

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Atrial fibrillation with RVR adult 10 mg IV not captured standing pages 89, 442, 534
Atrial fibrillation with RVR peds 0.25 mg/kg IV not captured standing pages 89, 442, 534
SVT adult 10 mg IV not captured standing pages 89, 442, 534
SVT peds 0.25 mg/kg IV not captured standing pages 89, 442, 534
Narrow-complex tachycardia adult 10 mg IV not captured standing pages 89, 442, 534
Narrow-complex tachycardia peds 0.25 mg/kg IV not captured standing pages 89, 442, 534

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 25–50 mg IV/IO/IM not captured standing pages 120, 443
Allergic reaction adult 25–50 mg IV/IO/IM not captured standing page 443
Allergic reaction peds 1–2 mg/kg IV/IO/IM not captured standing pages 120, 443
Allergic reaction peds 1–2 mg/kg IV/IO/IM not captured standing page 443
Anaphylaxis adult 25–50 mg IV/IO/IM not captured standing pages 120, 443
Anaphylaxis peds 1–2 mg/kg IV/IO/IM not captured standing pages 120, 443
Dystonic reaction adult 25–50 mg IV/IM not captured standing pages 443, 444
Dystonic reaction peds 1 mg/kg IV/IM not captured standing pages 443, 444
Nausea / vomiting adult 25–50 mg IV/IO/IM not captured standing pages 115, 443
Nausea / vomiting peds 1–2 mg/kg IV/IO/IM not captured standing pages 115, 443
Other adult 25–50 mg IV/IO/IM not captured standing page 443
Other peds 1–2 mg/kg IV/IO/IM not captured standing page 443
Procedural sedation adult 25–50 mg IV/IO/IM not captured standing page 443
Procedural sedation peds 1–2 mg/kg IV/IO/IM not captured standing page 443

Dobutamine

IndicationPopulationDoseRouteRepeatStandingSource
CHF / pulmonary edema adult 2–20 mcg/kg IV/IO not captured standing page 535
Hypotension / shock adult 2–20 mcg/kg IV/IO not captured standing page 535
Hypotension / shock adult 2–20 mcg/kg IV/IO not captured standing page 535
Other adult 2–20 mcg/kg IV/IO not captured standing page 535

Dopamine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 2–20 mcg/kg IV/IO not captured standing pages 92, 216
Bradycardia peds 2–20 mcg/kg IV/IO not captured standing pages 92, 216
Hypotension / shock adult 2–20 mcg/kg IV/IO not captured standing pages 106, 233
Hypotension / shock adult 2–20 mcg/kg IV/IO not captured standing pages 106, 233
Hypotension / shock peds 2–20 mcg/kg IV/IO not captured standing pages 106, 233
Hypotension / shock peds 2–20 mcg/kg IV/IO not captured standing pages 106, 233

Droperidol

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 0.625 mg IV/IO not captured standing pages 115, 447
Nausea / vomiting adult 2.5 mg IM not captured standing pages 115, 447
Procedural sedation adult 1.25–2.5 mg IV/IO not captured standing pages 134, 184, 447
Procedural sedation adult 5–10 mg IM not captured standing pages 134, 184, 447

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3–0.5 mg IM not captured standing pages 119, 227, 450, 451
Anaphylaxis peds 0.15–0.5 mg IM not captured standing pages 119, 227, 450, 451
Asthma / bronchospasm adult 0.3–0.5 mg IM/SQ not captured standing pages 102, 226, 450, 451
Asthma / bronchospasm peds 0.01 mg/kg IM/SQ not captured standing pages 102, 226, 450, 451
Cardiac arrest adult 1 mg IV/IO not captured standing pages 69, 77, 212, 248
Cardiac arrest peds 0.01 mg/kg IV/IO not captured standing pages 69, 77, 212, 248
Croup adult 3 mg NEB not captured standing pages 120, 226, 228, 450, 451
Croup peds 3 mg NEB not captured standing pages 120, 226, 228, 450, 451
Hypotension / shock adult 0.05–1 mcg/kg IV/IO not captured standing pages 92, 96, 105, 120, 228, 233, 450, 451
Hypotension / shock adult 0.05–1 mcg/kg IV/IO not captured standing pages 92, 96, 105, 120, 228, 233, 450, 451
Hypotension / shock adult 20 mcg IV/IO not captured standing pages 96, 105, 120, 228, 233, 451, 452
Hypotension / shock peds 0.05–1 mcg/kg IV/IO not captured standing pages 92, 96, 105, 120, 228, 233, 450, 451
Hypotension / shock peds 0.05–1 mcg/kg IV/IO not captured standing pages 92, 96, 105, 120, 228, 233, 450, 451

Etomidate

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 0.2–0.4 mg/kg IV/IO not captured standing page 455
RSI induction peds 0.2–0.4 mg/kg IV/IO not captured standing page 455

Famotidine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 20 mg IV/IO not captured standing page 120
Allergic reaction adult 20 mg IV/IO not captured standing page 120
Allergic reaction adult 20–40 mg PO not captured standing page 120
Allergic reaction adult 20–40 mg PO not captured standing page 120
Allergic reaction peds 0.5 mg/kg IV/IO not captured standing page 120
Allergic reaction peds 0.5 mg/kg IV/IO not captured standing page 120
Allergic reaction peds 20 mg PO not captured standing page 120
Allergic reaction peds 20 mg PO not captured standing page 120
Anaphylaxis adult 20 mg IV/IO not captured standing page 120
Anaphylaxis adult 20–40 mg PO not captured standing page 120
Anaphylaxis peds 0.5 mg/kg IV/IO not captured standing page 120
Anaphylaxis peds 20 mg PO not captured standing page 120

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 mcg/kg IV/IO/IM/IN not captured standing pages 81, 459
Severe pain adult 1 mcg/kg IV/IO/IM/IN not captured standing pages 81, 124, 240, 459
Severe pain peds 1–2 mcg/kg IV/IO/IM/IN not captured standing pages 81, 124, 240, 459
G–L Glucagon, Haloperidol, Hydromorphone, Hydroxocobalamin, Insulin, Ipratropium, Ketamine, Levetiracetam, Lidocaine, Lorazepam10

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 1–2 mg IV/IM not captured standing pages 195, 461
Beta-blocker / calcium-channel-blocker overdose adult 1–2 mg IV/IM not captured standing pages 195, 461
Hypoglycemia adult 1 mg IM not captured standing pages 109, 111, 461

Haloperidol

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5–10 mg IV/IM not captured standing page 463

Hydromorphone

IndicationPopulationDoseRouteRepeatStandingSource
Severe pain adult 0.5 mg IV/IM not captured standing page 465

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 g IV not captured standing page 435

Insulin

IndicationPopulationDoseRouteRepeatStandingSource
Hyperglycemia / DKA adult 0.05–0.1 unit/kg IV/IO not captured standing page 541
Hyperglycemia / DKA peds 0.05–0.1 unit/kg IV/IO not captured standing page 541
Hyperkalemia adult 0.05–0.1 unit/kg IV/IO not captured standing page 541
Hyperkalemia peds 0.05–0.1 unit/kg IV/IO not captured standing page 541
Other adult 0.05–0.1 unit/kg IV/IO not captured standing page 541
Other adult 0.05–0.1 unit/kg IV/IO not captured standing page 541
Other peds 0.05–0.1 unit/kg IV/IO not captured standing page 541
Other peds 0.05–0.1 unit/kg IV/IO not captured standing page 541

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 0.5 mg NEB not captured standing pages 101, 119, 192, 303, 467
Asthma / bronchospasm peds 0.5 mg NEB not captured standing pages 101, 119, 192, 303, 467

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–2 mg/kg IV/IO not captured standing pages 70, 77
Mild to moderate pain adult 0.2 mg/kg IV/IO/IM not captured standing pages 124, 240, 470
Mild to moderate pain peds 0.2 mg/kg IV/IO/IM not captured standing pages 124, 240, 470
RSI induction adult 1–2 mg/kg IV/IO not captured standing pages 258, 470
RSI induction peds 1–2 mg/kg IV/IO not captured standing pages 258, 470

Levetiracetam

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 500–2000 mg IV/IO not captured standing page 543
Other peds 20 mg/kg IV/IO not captured standing page 543
Seizure adult 500–2000 mg IV/IO not captured standing page 543
Seizure peds 20 mg/kg IV/IO not captured standing page 543

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–1.5 mg/kg IV/IO not captured standing pages 87, 473
Other adult 20–40 mg IO not captured standing pages 473, 474
Other peds 0.5 mg/kg IO not captured standing pages 473, 474
VF / pulseless VT adult 1–1.5 mg/kg IV/IO not captured standing pages 69, 77, 473
VF / pulseless VT peds 1 mg/kg IV/IO not captured standing pages 69, 77, 473

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 0.5–2 mg IV/IO not captured standing page 476
Agitation adult 2 mg IM not captured standing page 476
Other adult 0.05 mg/kg IV/IO not captured standing page 476
Other peds 0.05 mg/kg IV/IO not captured standing page 476
Procedural sedation adult 0.5–2 mg IV/IO not captured standing page 476
Procedural sedation adult 2 mg IM not captured standing page 476
Procedural sedation peds 0.05–0.1 mg/kg IV/IO not captured standing page 476
Procedural sedation peds 0.1 mg/kg IM not captured standing page 476
Status epilepticus adult 1–2 mg IV/IO not captured standing pages 109, 476
Status epilepticus adult 1–2 mg IM not captured standing pages 109, 476
Status epilepticus peds 0.1 mg/kg IV/IO not captured standing pages 109, 476
Status epilepticus peds 0.1 mg/kg IM not captured standing pages 109, 476
M–O Magnesium Sulfate, Mannitol, Methylprednisolone, Midazolam, Morphine, Naloxone, Nerve Agent Antidote Kit, Nicardipine, Nitroglycerin, Ondansetron, Oral Glucose, Oxytocin12

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Eclampsia / pre-eclampsia adult 10 g IM not captured standing page 150
Eclampsia / pre-eclampsia adult 4 g IV/IO not captured standing pages 150, 479
Eclampsia / pre-eclampsia adult 4 g IV/IO not captured standing pages 150, 480
Other adult 2 g IV/IO not captured standing pages 69, 77, 479, 480
Other adult 2 g IV/IO not captured standing pages 102, 480
Other peds 25–50 mg/kg IV/IO not captured standing pages 69, 77, 479, 480
Other peds 25–50 mg/kg IV/IO not captured standing pages 102, 480

Mannitol

IndicationPopulationDoseRouteRepeatStandingSource
Head injury / TBI adult 1.5–2 g/kg IV not captured standing page 545
Head injury / TBI peds 0.25–0.5 g/kg IV not captured standing page 545
Other adult 1.5–2 g/kg IV not captured standing page 545
Other adult 1.5–2 g/kg IV not captured standing page 545
Other adult 1.5–2 g/kg IV not captured standing page 545
Other adult 1.5–2 g/kg IV not captured standing page 545
Other peds 0.25–0.5 g/kg IV not captured standing page 545
Other peds 0.25–0.5 g/kg IV not captured standing page 545
Other peds 0.25–0.5 g/kg IV not captured standing page 545
Other peds 0.25–0.5 g/kg IV not captured standing page 545

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 125 mg IV/IO/IM not captured standing page 483
Anaphylaxis peds 1–2 mg/kg IV/IO/IM not captured standing page 483
Asthma / bronchospasm adult 125 mg IV/IO/IM not captured standing page 483
Asthma / bronchospasm peds 1–2 mg/kg IV/IO/IM not captured standing page 483
Other adult 125 mg IV/IO/IM not captured standing pages 102, 483
Other peds 1–2 mg/kg IV/IO/IM not captured standing pages 102, 483

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2.5 mg IN not captured standing pages 134, 184
Other adult 2.5 mg IN not captured standing page 139
Other adult 5 mg IN not captured standing page 203
Other adult 5 mg IM not captured standing page 203
Other peds 0.05–0.1 mg/kg IV/IO/IM not captured standing page 139
Other peds 0.2 mg/kg IN not captured standing page 139
Procedural sedation adult 2.5 mg IN not captured standing page 91
Seizure adult 2.5 mg IN not captured standing pages 109, 231, 485, 486
Seizure adult 5 mg IM not captured standing pages 109, 231, 485, 486
Seizure peds 0.1 mg/kg IV/IO not captured standing pages 109, 231, 485, 486
Seizure peds 0.2 mg/kg IN not captured standing pages 109, 231, 485, 486
Seizure peds 0.2 mg/kg IM not captured standing pages 109, 231, 485, 486

Morphine

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 0.1 mg/kg IV/IO/IM not captured standing pages 81, 124, 240, 487
Mild to moderate pain peds 0.1 mg/kg IV/IO/IM not captured standing pages 81, 124, 240, 487

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Opioid overdose adult 2–4 mg IM/IN not captured standing pages 181, 243, 489
Opioid overdose peds 2–4 mg IM/IN not captured standing pages 181, 243, 489
Other peds 0.1 mg/kg IV/IO not captured standing page 199
Other peds 0.1 mg/kg IM/IN not captured standing page 199

Nerve Agent Antidote Kit

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 2.1 mg IM not captured standing pages 353, 354
Nerve agent exposure peds 2.1 mg IM not captured standing pages 353, 354
Organophosphate poisoning adult 2.1 mg IM not captured standing pages 353, 354
Organophosphate poisoning peds 2.1 mg IM not captured standing pages 353, 354

Nicardipine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5 mg IV/IO not captured standing page 551

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 81, 93, 491
ACS / chest pain adult 0.5–1.5 inch TD not captured standing pages 81, 94, 492
CHF / pulmonary edema adult 0.4 mg SL not captured standing pages 93, 491
Other adult 0.8 mg SL not captured standing pages 93, 492

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 4 mg ODT not captured standing pages 115, 497
Nausea / vomiting adult 4 mg IV/IO/IM not captured standing pages 115, 497
Nausea / vomiting peds 0.15 mg/kg IV/IO/IM not captured standing pages 115, 497
Nausea / vomiting peds 4 mg ODT not captured standing pages 115, 497

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 15–45 g PO not captured standing page 499
Hypoglycemia peds 5–45 g PO not captured standing page 499

Oxytocin

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 10 unit IV/IO not captured standing pages 153, 501
Obstetric hemorrhage adult 10 unit IM not captured standing pages 153, 501
P–R Phenylephrine, Phenytoin, Potassium Chloride, Proton Pump Inhibitors, Ranitidine, Rocuronium6

Phenylephrine

IndicationPopulationDoseRouteRepeatStandingSource
Hypotension / shock adult 50–200 mcg IV/IO not captured standing page 559
Other adult 1 spray IN not captured standing pages 141, 503
Other peds 1 spray IN not captured standing pages 141, 503
RSI induction adult 2–4 spray IN not captured standing page 503
RSI induction peds 1–2 spray IN not captured standing page 503

Phenytoin

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 10–15 mg/kg IV/IO not captured standing page 561
Other adult 100 mg IV/IO not captured standing page 561
Other peds 10–15 mg/kg IV/IO not captured standing page 561
Seizure adult 10–15 mg/kg IV/IO not captured standing page 561
Seizure peds 10–15 mg/kg IV/IO not captured standing page 561

Potassium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 20–60 mEq IV/IO not captured standing pages 565, 566
Other peds 0.5–1 mEq/kg IV/IO not captured standing pages 565, 566

Proton Pump Inhibitors

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 20–80 mg IV/IO not captured standing page 569
Other adult 20–80 mg IV/IO not captured standing page 569
Other adult 20–80 mg IV/IO not captured standing page 569
Trauma / hemorrhage adult 20–80 mg IV/IO not captured standing page 569

Ranitidine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 150–300 mg PO not captured standing page 505
Anaphylaxis adult 50 mg IV/IO/IM not captured standing page 505
Anaphylaxis peds 1 mg/kg IV/IO/IM not captured standing page 505
Anaphylaxis peds 150 mg PO not captured standing page 505

Rocuronium

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 mg/kg IV/IO not captured standing page 95
Other peds 1 mg/kg IV/IO not captured standing page 95
RSI induction adult 1 mg/kg IV/IO not captured standing page 259
RSI induction peds 1 mg/kg IV/IO not captured standing page 259
S–Z Sodium Bicarbonate, Sodium Nitroprusside, Succinylcholine, Thrombolytics-Fibrinolytics, Tranexamic Acid, Vasopressin, Vecuronium7

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 1 mEq/kg IV/IO not captured standing pages 70, 77, 145
Hyperkalemia peds 1 mEq/kg IV/IO not captured standing pages 70, 77, 145
Other adult 1 mEq/kg IV not captured standing page 166
Other adult 1 mEq/kg IV/IO not captured standing page 509
Other peds 1 mEq/kg IV/IO not captured standing page 509
Tricyclic overdose adult 1 mEq/kg IV/IO not captured standing pages 70, 77, 187, 244
Tricyclic overdose peds 1 mEq/kg IV/IO not captured standing pages 70, 77, 187, 244

Sodium Nitroprusside

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.3–5 mcg/kg IV/IO not captured standing pages 571, 572

Succinylcholine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–2 mg/kg IV/IO/IM not captured standing page 511
Other peds 1–2 mg/kg IV/IO/IM not captured standing page 511

Thrombolytics-Fibrinolytics

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 15 mg/kg IV/IO not captured standing pages 573, 574
Other adult 0.9 mg/kg IV/IO not captured standing page 573
Other adult 2 g IV/IO not captured standing page 573
Other adult 2 g IV/IO not captured standing page 573
Other peds 15 mg/kg IV/IO not captured standing page 573

Tranexamic Acid

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 g IV/IO not captured standing pages 156, 515
Other adult 2 g IV/IO not captured standing pages 154, 515
Other peds 10 mg/kg IN not captured standing pages 142, 515
Other peds 15 mg/kg IV/IO not captured standing pages 156, 515
Trauma / hemorrhage adult 500 mg NEB not captured standing pages 142, 516
Trauma / hemorrhage peds 10 mg/kg NEB not captured standing pages 142, 516

Vasopressin

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 40 unit IV/IO not captured standing page 575
Hypotension / shock adult 0.01–0.1 unit IV/IO not captured standing page 575
Sepsis adult 0.01–0.1 unit IV/IO not captured standing page 575

Vecuronium

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.1 mg/kg IV/IO not captured standing page 95
Other adult 0.1 mg/kg IV/IO not captured standing pages 259, 519
Other peds 0.1 mg/kg IV/IO not captured standing pages 259, 519
Cite this

Ada County-City Emergency Services System, United States EMS Protocol Census. 250 dose entries, effective 2026-02-01.

https://protoquiz.com/census/agencies/ada-county-city-emergency-services-system/

Outdated or wrong? Fix or remove itAll Idaho agenciesMethodologyData licenseStudy these protocols in the app

The census is free and not for sale. Only public agencies are named.

Training reference compiled from published protocols. Not a clinical order. Verify with your agency and medical director.